TRL-AAG2-3
gene geneOn this page
Also known as tRNA-Leu-AAG-2-3
Summary
TRL-AAG2-3 (tRNA-Leu (anticodon AAG) 2-3, HGNC:12315) is a gene on chromosome 14q11.2.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12315 |
| Approved symbol | TRL-AAG2-3 |
| Name | tRNA-Leu (anticodon AAG) 2-3 |
| Location | 14q11.2 |
| Locus type | RNA, transfer |
| Status | Approved |
| Aliases | tRNA-Leu-AAG-2-3 |
| OMIM | 189932 |
| Entrez | 7207 |
| RNAcentral | URS0000120E41 — tRNA, 82 nt, 128 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression. (PMID:17656376)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
GOBP_HINDBRAIN_DEVELOPMENT, GOBP_METENCEPHALON_DEVELOPMENT, GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS, LINDGREN_BLADDER_CANCER_CLUSTER_3_DN, BRUECKNER_TARGETS_OF_MIRLET7A3_DN, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, GOBP_CEREBELLAR_CORTEX_DEVELOPMENT, WANG_LMO4_TARGETS_DN, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_HEAD_DEVELOPMENT, GOBP_HINDBRAIN_MORPHOGENESIS, CTCTATG_MIR368, GOCC_EUCHROMATIN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, chr1p36
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
322 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:26994570:G:GT | donor_gain | 1.0000 |
| 1:26994554:GAC:G | donor_gain | 0.9900 |
| 1:26994576:G:GT | donor_gain | 0.9900 |
| 1:26994550:G:GT | donor_gain | 0.9800 |
| 1:26994571:A:T | donor_gain | 0.9800 |
| 1:26994604:G:GT | donor_gain | 0.9800 |
| 1:26994607:GC:G | donor_gain | 0.9800 |
| 1:26994577:C:CA | donor_gain | 0.9600 |
| 1:26994578:A:AA | donor_gain | 0.9600 |
| 1:26999845:A:AG | acceptor_gain | 0.9400 |
| 1:26999846:G:GG | acceptor_gain | 0.9400 |
| 1:26994570:G:T | donor_gain | 0.9000 |
| 1:26994609:TGAG:T | donor_loss | 0.9000 |
| 1:26994610:GAGG:G | donor_loss | 0.9000 |
| 1:26994611:AG:A | donor_loss | 0.9000 |
| 1:26994612:GGTG:G | donor_loss | 0.9000 |
| 1:26994613:G:GC | donor_loss | 0.9000 |
| 1:26995498:C:G | donor_gain | 0.9000 |
| 1:26999846:GCTC:G | acceptor_gain | 0.8900 |
| 1:26994580:T:G | donor_gain | 0.8800 |
| 1:26994597:A:AG | donor_gain | 0.8700 |
| 1:26994598:G:GG | donor_gain | 0.8700 |
| 1:26994778:G:GA | donor_gain | 0.8500 |
| 1:26994285:T:TA | donor_gain | 0.8400 |
| 1:26999842:TCCA:T | acceptor_loss | 0.8400 |
| 1:26999843:CCAG:C | acceptor_loss | 0.8400 |
| 1:26999844:CAGCT:C | acceptor_loss | 0.8400 |
| 1:26999845:A:AC | acceptor_loss | 0.8400 |
| 1:26999846:G:GC | acceptor_loss | 0.8400 |
| 1:26999837:T:G | acceptor_loss | 0.8300 |
AlphaMissense
0 scored. Top likely-pathogenic:
Disease associations
OMIM: gene MIM:189932 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.